BRIACELL THERAPEUTICS CORP. Interest Expense
BRIACELL THERAPEUTICS CORP. (BCTX) reported Interest Expense of $979 for the 12-month period ending 2022-07-31, per its 10-K filed 2023-10-25.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-10-25
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2022-07-31 was $0.00.
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2022-04-30 was $0.00.
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2022-01-31 was $0.00.
- BRIACELL THERAPEUTICS CORP. interest expense for the quarter ending 2021-10-31 was $979.00.
- BRIACELL THERAPEUTICS CORP. interest expense for fiscal 2022 was $979.00, a 98.75% decline from fiscal 2021.
- BRIACELL THERAPEUTICS CORP. interest expense for fiscal 2021 was $78.55K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-25 | $0.00 derived: sum of 2 quarters · filed 2023-10-25 | $0.00 derived: sum of 3 quarters · filed 2023-10-25 | $979.00 10-K · filed 2023-10-25 |
| 2022-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-14 | $0.00 derived: sum of 2 quarters · filed 2023-06-14 | $979.00 10-Q · filed 2023-06-14 | |
| 2022-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-16 | $979.00 10-Q · filed 2023-03-16 | ||
| 2021-10-31 | $979.00 10-Q · filed 2022-12-14 | |||
| 2021-07-31 | $78.55K 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |